Research Profile

Michael Murphy

Biography

In February 2007, Dr Michael Murphy became President of University College Cork.
Dr Murphy, who is a graduate of UCC's Medical School, was appointed Professor of Clinical Pharmacology and Head of the Department of Pharmacology and Therapeutics at UCC in 1992. He became Dean of the Faculty of Medicine and Health in 2000 and Head of the College of Medicine and Health in 2006. During this period he managed a programme of expansion and diversification, increasing the number of professional degree programmes from two (Medicine and Dentistry) to six (Nursing, Pharmacy, Speech Therapy and Occupational therapy), which now provides education, training and research opportunities for almost 3,000 students. The associated capital investment programme, the largest since the foundation of the faculty in 1845, exceeds 120 million.
Dr Murphy previously held senior positions at the University of Chicago and at the Royal Postgraduate Medical School London, and worked at St Vincent's University Hospital Dublin and St Finbarr's Hospital Cork.
Dr Murphy's external leadership roles have included membership of many international and domestic professional organisations, including government and industrial advisory panels.  His board membership has included the Irish Health Service Executive and the Health Research Board of Ireland. 
Dr Murphy has published extensively, with over 100 original publications on therapeutic strategies for cardiovascular risk factors and disease.  He has led several large-scale international research projects and clinical trials, and has been widely cited in the literature of medical research.
He is married to Siobán and has three children.

Research Interests

My research interests have focussed on the basic and clinical pharmacology of drugs acting on the cardiovascular system, particularly in the management of risk factors for cardiovascular disease. I have occasionally strayed into the measurement and prevalence of these factors in various populations. My outputs in this regard are best detailed through a record of funding acquired and of publications arising from the work.

Publications

Book Chapters

 YearPublication
(2004)'The prospective study of Pravastatin in the elderly at risk (PROSPER) Study'
Shepherd J, Blauw GJ, Murphy MB, gaw A; (2004) 'The prospective study of Pravastatin in the elderly at risk (PROSPER) Study' In: Statins: The HMGCoA Reductase Inhibitors in Perspective. [Details]

Peer Reviewed Journals

 YearPublication
(2010)'KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study'
Iakoubova, Olga A; Robertson, Michele; Tong, Carmen H; Rowland, Charles M; Catanese, Joseph J; Blauw, Gerard J; Jukema, JW; Murphy, Michael B; Devlin, James J; Ford, Ian; Shepherd, James; (2010) 'KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study'. European Journal of Cardiovascular Prevention & Rehabilitation, 17 (4):455-461 [DOI] [Details]
(2008)'Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?'
Kitabchi, Abbas E. and Murphy, Mary Beth and Spencer, Judy and Matteri, Robert and Karas, Jim; (2008) 'Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?'. DIABETES CARE, 31 (11):2081-2085 [DOI] [Details]
(2008)'Modulation of steroidogenesis by coastal waters and sewage effluents of Hong Kong, China, using the H295R assay'
Gracia, Tannia and Jones, Paul D. and Higley, Eric B. and Hilscherova, Klara and Newsted, John L. and Murphy, Margaret B. and Chan, Alice K. Y. and Zhang, Xiaowei and Hecker, Markus and Lam, Paul K. S. and Wu, Rudolf S. S. and Giesy, John P.; (2008) 'Modulation of steroidogenesis by coastal waters and sewage effluents of Hong Kong, China, using the H295R assay'. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 15 (4):332-343 [DOI] [Details]
(2008)'Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line'
Song, Renfang and He, Yuhe and Murphy, Margaret B. and Yeung, Leo W. Y. and Yu, Richard M. K. and Lam, Michael H. W. and Lam, Paul K. S. and Hecker, Markus and Giesy, John P. and Wu, Rudolf S. S. and Zhang, Wenbing and Sheng, Guoying and Fu, Jiamo; (2008) 'Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line'. CHEMOSPHERE, 71 (10):1888-1894 [DOI] [Details]
(2008)'Synthetic polycyclic musks in Hong Kong sewage sludge'
Shek, W. M. and Murphy, M. B. and Lam, James C. W. and Lam, Paul K. S.; (2008) 'Synthetic polycyclic musks in Hong Kong sewage sludge'. CHEMOSPHERE, 71 (7):1241-1250 [DOI] [Details]
(2008)'Effects of 20 PBDE metabolites on steroidogenesis in the H295R cell line'
He, Yuhe and Murphy, Margaret B. and Yu, Richard M. K. and Lam, Michael H. W. and Hecker, Markus and Giesy, John P. and Wu, Rudolf S. S. and Lam, Paul K. S.; (2008) 'Effects of 20 PBDE metabolites on steroidogenesis in the H295R cell line'. TOXICOLOGY LETTERS, 176 (3):230-238 [DOI] [Details]
(2008)'THE ILLNESS INTRUSIVENESS OF A HEPATITIS C DIAGNOSIS'
Murphy, Madeleine B.; (2008) 'THE ILLNESS INTRUSIVENESS OF A HEPATITIS C DIAGNOSIS'. HEPATOLOGY, 48 (4, Suppl. S) [Details]
(2008)'Thirty years of personal experience in hyperglycemic crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state'
Kitabchi, Abbas E. and Umpierrez, Guillermo E. and Fisher, Joseph N. and Murphy, Mary Beth and Stentz, Frankie B.; (2008) 'Thirty years of personal experience in hyperglycemic crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state'. JOURNAL OF CLINICAL ENDOCRINOLOGY \& METABOLISM, 93 (5):1541-1552 [DOI] [Details]
(2007)'Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds'
Gracia, Tannia and Hilscherova, Klara and Jones, Paul D. and Newsted, John L. and Higley, Eric B. and Zhang, Xiaowel and Hecker, Markus and Murphy, Margaret B. and Yu, Richard M. K. and Lam, Paul K. S. and Wu, Rudolf S. S. and Giesy, John P.; (2007) 'Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds'. TOXICOLOGY AND APPLIED PHARMACOLOGY, 225 (2):142-153 [DOI] [Details]
(2007)'Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line'
Ding, Ling and Murphy, Margaret B. and He, Yuhe and Xu, Yan and Yeung, Leo W. Y. and Wang, Jingxian and Zhou, Bingsheng and Lam, Paul K. S. and Wu, Rudolf S. S. and Giesy, John P.; (2007) 'Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line'. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 26 (4):764-772 [Details]
(2007)'Long-term effect of diabetes and its treatment on cognitive function'
Genuth, S. and Nathan, D. M. and Zinman, B. and Crofford, O. and Crandall, J. and Phillips, M. and Reid, M. and Brown-Friday, J. and Engel, S. and Sheindlin, J. and Martinez, H. and Shamoon, H. and Engel, H. and Dahms, W. and Palmert, M. and Mayer, L. and Pendegras, S. and Zegarra, H. and Miller, D. and Singerman, L. and Smith-Brewer, S. and Gubitosi-Klug, R. and Gaston, P. and Genuth, S. and Brillon, D. and Lackaye, M. E. and Reppucci, V. and Lee, T. and Heinemann, M. and Whitehouse, F. and McLellan, M. and Kruger, D. and Carey, J. D. and Angus, E. and Croswell, M. and Galpirn, A. and Bergenstal, R. and Johnson, M. and Spencer, M. and Morgan, K. and Etzwiler, D. and Kendall, D. and Noller, D. and Jacobson, A. and Golden, E. and Beaser, R. and Ganda, O. and Hamdy, O. and Rosenzweig, J. an; (2007) 'Long-term effect of diabetes and its treatment on cognitive function'. NEW ENGLAND JOURNAL OF MEDICINE, 356 (18):1842-1852 [Details]
(2006)'Hyperglycemic crises in adult patients with diabetes'
Kitabchi, Abbas E. and Umpierrez, Guillermo E. and Murphy, Mary Beth and Kreisberg, Robert A.; (2006) 'Hyperglycemic crises in adult patients with diabetes'. DIABETES CARE, 29 (12):2739-2748 [DOI] [Details]
(2006)'Evaluation of the methoxytriazine herbicide prometon using a short-term fathead minnow reproduction test and a suite of in vitro bioassays'
Villeneuve, Daniel L. and Murphy, Margaret B. and Kahl, Michael D. and Jensen, Kathleen M. and Butterworth, Brian C. and Makynen, Elizabeth A. and Durhan, Elizabeth J. and Linnum, Ann and Leino, Richard L. and Curtis, Lawrence R. and Giesy, John P. and Ankley, Gerald T.; (2006) 'Evaluation of the methoxytriazine herbicide prometon using a short-term fathead minnow reproduction test and a suite of in vitro bioassays'. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 25 (8):2143-2153 [Details]
(2006)'Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: Hormone production'
Hecker, Markus and Newsted, John L. and Murphy, Margaret B. and Higley, Eric B. and Jones, Paul D. and Wu, Rudolf and Giesy, John P.; (2006) 'Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: Hormone production'. TOXICOLOGY AND APPLIED PHARMACOLOGY, 217 (1):114-124 [DOI] [Details]
(2006)'Sediment TCDD-EQs and EROD and MROD activities in ranid frogs from agricultural and nonagricultural sites in Michigan (USA)'
Murphy, M. B. and Hecker, M. and Coady, K. K. and Tompsett, A. R. and Jones, P. D. and Newsted, J. L. and Wong, H. L. and du Preez, L. H. and Solomon, K. R. and Carr, J. A. and Smith, E. E. and Kendall, R. J. and Van der Kraak, G. and Giesy, J. P.; (2006) 'Sediment TCDD-EQs and EROD and MROD activities in ranid frogs from agricultural and nonagricultural sites in Michigan (USA)'. ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 51 (3):467-477 [DOI] [Details]
(2006)'Four-dimensional imaging and quantification of gene expression in early developing zebrafish (Danio rerio) embryos'
Yu, RMK and Lin, CC and Chan, PK and Chow, ESH and Murphy, MB and Chan, BP and Muller, F and Strahle, U and Cheng, SH; (2006) 'Four-dimensional imaging and quantification of gene expression in early developing zebrafish (Danio rerio) embryos'. TOXICOLOGICAL SCIENCES, 90 (2):529-538 [DOI] [Details]
(2006)'Induction of cytochrome P4501A in African brown house snake (Lamprophis fuliginosus) primary hepatocytes'
Hecker, M and Murphy, MB and Giesy, JP and Hopkins, WA; (2006) 'Induction of cytochrome P4501A in African brown house snake (Lamprophis fuliginosus) primary hepatocytes'. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 25 (2):496-502 [Details]
(2006)'Effects of PCBs and MeSO2-PCBs on adrenocortical steroidogenesis in H295R human adrenocortical carcinoma cells'
Xu, Y and Yu, RMK and Zhang, XW and Murphy, MB and Giesy, JP and Lam, MHW and Lam, PKS and Wu, RSS and Yu, HX; (2006) 'Effects of PCBs and MeSO2-PCBs on adrenocortical steroidogenesis in H295R human adrenocortical carcinoma cells'. CHEMOSPHERE, 63 (5):772-784 [DOI] [Details]
(2005)'Role of insulin secretion and sensitivitv in the evolution of type 2 diabetes in the diabetes prevention program - Efects of lifestyle intervention and metformin'
Kitabchi, AE and Temprosa, M and Knowler, WC and Kahn, SE and Fowler, SE and Haffner, SM and Andres, R and Saudek, C and Edelstein, SL and Arakaki, R and Murphy, MB and Shamoon, H and Diabet Prevention Program Res Grp; (2005) 'Role of insulin secretion and sensitivitv in the evolution of type 2 diabetes in the diabetes prevention program - Efects of lifestyle intervention and metformin'. DIABETES, 54 (8):2404-2414 [Details]
(2005)'Effects of atrazine on CYP19 gene expression and aromatase activity in testes and on plasma sex steroid concentrations of male African clawed frogs (Xenopus laevis)'
Hecker, M and Park, JW and Murphy, MB and Jones, PD and Solomon, KR and Van Der Kraak, G and Carr, JA and Smith, EE and du Preez, L and Kendall, RJ and Giesy, JP; (2005) 'Effects of atrazine on CYP19 gene expression and aromatase activity in testes and on plasma sex steroid concentrations of male African clawed frogs (Xenopus laevis)'. TOXICOLOGICAL SCIENCES, 86 (2):273-280 [DOI] [Details]
(2005)'Effects of atrazine on metamorphosis, growth, laryngeal and gonadal development, aromatase activity, and sex steroid concentrations in Xenopus laevis'
Coady, KK and Murphy, MB and Villeneuve, DL and Hecker, M and Jones, PD and Carr, JA and Solomon, KR and Smith, EE and Van der Kraak, G and Kendall, RJ and Giesy, JP; (2005) 'Effects of atrazine on metamorphosis, growth, laryngeal and gonadal development, aromatase activity, and sex steroid concentrations in Xenopus laevis'. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 62 (2):160-173 [DOI] [Details]
(2004)'Effects of atrazine on metamorphosis, growth, and gonadal development in the green frog (Rana clamitans)'
Coady, KK and Murphy, MB and Villeneuve, DL and Hecker, M and Jones, PD and Carr, JA and Solomon, KR and Smith, EE and Van der Kraak, G and Kendall, RJ and Giesy, JP; (2004) 'Effects of atrazine on metamorphosis, growth, and gonadal development in the green frog (Rana clamitans)'. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 67 (12):941-957 [DOI] [Details]
(2003)'Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy - The Epidemiology of Diabetes Interventions and Complications (EDIC) study'
Steffes, MW and Chavers, BM and Molitch, ME and Cleary, PA and Lachin, JM and Genuth, S and Nathan, DM and Genuth, S and Nathan, D and Engel, S and Martinez, H and Shamoon, H and Engel, H and Dahms, W and Mayer, L and Pendegras, S and Zegarra, H and Miller, D and Singerman, L and Smith-Brewer, S and Genuth, S and Brillion, D and Lackaye, M and Heinemann, M and Repucci, V and Lee, T and Whitehouse, F and Kruger, D and Galpern, A and Carey, JD and Bergenstal, R and Johnson, M and Kendell, D and Spencer, M and Noller, D and Morgan, K and Etzwiler, D and Jacobson, A and Golden, E and Sharuk, G and ARrigg, P and Baeser, R and Ganda, O and Rosenzweig, J and Wolpert, H and Economides, P and Handy, O and Rand, L and Nathan, D and Fritz, S and Godine, J and McKitrick, C and Lou, P and Service, FJ ; (2003) 'Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy - The Epidemiology of Diabetes Interventions and Complications (EDIC) study'. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 290 (16):2159-2167 [Details]
(2003)'Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus'
Engel, S and Martinez, H and Shamoon, H and Engel, H and Dahms, W and Mayer, L and Pendegras, S and Zegarra, H and Miller, D and Singerman, L and Smith-Brewer, S and Genuth, S and Brillon, D and Lackaye, M and Heinemann, M and Reppuci, V and Lee, T and Whitehouse, F and Kruger, D and Galpern, A and Carey, JD and Bergenstal, R and Johnson, M and Kendall, D and Spencer, M and Noller, D and Morgan, K and Etzwiler, D and Jacobson, A and Golden, E and Sharuk, G and Arrigg, P and Baeser, R and Ganda, O and Rosenzweig, J and Wolpert, H and Economides, P and Handy, O and Rand, L and Nathan, D and Fritz, S and Godine, J and McKitrick, C and Lou, P and Service, FJ and Ziegler, G and Pach, J and Lindsey, J and Colwell, J and Wood, D and Mayfield, R and Hermayer, K and Szpiech, M and Lyons, T and Par; (2003) 'Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus'. NEW ENGLAND JOURNAL OF MEDICINE, 348 (23):2294-2303 [Details]
(2003)'Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes'
Brancati, F and Charleston, J and Cheskin, L and Clark, J and DiGregorio-Celnik, D and Friedman-Donze, L and Rubin, R and Stewart, K and Bray, GA and DeLee, DG and Boss, KR and Greenway, FL and Lovejoy, JC and Ryan, DH and Williamson, DA and West, DS and DiLillo, V and Raczynski, JM and Lewis, CE and Oberman, A and Thomas, S and Nathan, DM and Horton, ES and Turgeon, H and Jackson, SD and Blackburn, GL and Delahanty, L and Steiner, B and Cagliero, E and Mantzoros, C and Hill, JO and Phillipp, J and Hamman, RF and Schwartz, R and Regensteiner, J and Van Dorsten, B and McDermott, MT and Dills, DG and Foreyt, JP and Reeves, RS and Pownell, HJ and Balasubramanyam, A and Jones, PH and Saad, MF and Jinagouda, S and Chiu, K and Morales, L and Ghazarian, S and Navarrete, G and Iqbal, N and Szamos; (2003) 'Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes'. CONTROLLED CLINICAL TRIALS, 24 (5):610-628 [DOI] [Details]
(2003)'Thyroid dysfunction in patients with type 1 diabetes - A longitudinal study'
Umpierrez, GE and Latif, KA and Murphy, MB and Lambeth, HC and Stentz, F and Bush, A and Kitabchi, AE; (2003) 'Thyroid dysfunction in patients with type 1 diabetes - A longitudinal study'. DIABETES CARE, 26 (4):1181-1185 [Details]
(2002)'Effects of telmisartan versus hydrochlorothiazide on albumin excretion in isolated systolic hypertension. A sub-study from the ARAMIS study'
Vogt, L and Navis, G and Koester, J and Seewaldt-Becker, E and Manolis, AJ and Reid, JL and Murphy, MB and de Zeeuw, D; (2002) 'Effects of telmisartan versus hydrochlorothiazide on albumin excretion in isolated systolic hypertension. A sub-study from the ARAMIS study'. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13 (Suppl. S) [Details]
(2002)'The white-coat effect is associated with increased blood pressure reactivity to physical activity'
Leary, AC and Donnan, PT and MacDonald, TM and Murphy, MB; (2002) 'The white-coat effect is associated with increased blood pressure reactivity to physical activity'. BLOOD PRESSURE MONITORING, 7 (4):209-213 [Details]
(2001)'Hyperglycemic crises in patients with diabetes mellitus'
Kitabchi, AE and Umpierrez, GE and Murphy, MB and Barrett, EJ and Kriesberg, RA and Malone, JI and Wall, BM and Am Diabet Assoc; (2001) 'Hyperglycemic crises in patients with diabetes mellitus'. DIABETES CARE, 24 (1):154-161 [Details]
(2001)'Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)'
Genuth, S and Nathan, D and Shamoon, H and Duffy, H and Engel, S and Engel, H and Dahms, W and Mayer, L and Pendegras, S and Zegarra, H and Miller, D and Singerman, L and Brillion, D and Lackaye, M and Heinemann, M and Rahhal, F and Reppuci, V and Lee, T and Whitehouse, F and Kruger, D and Carey, JD and Bergenstal, R and Johnson, M and Kendall, D and Spencer, M and Noller, D and Morgan, K and Etzwiler, D and Jacobson, A and Golden, E and Soroko, D and Sharuk, G and Arrigg, P and Doyle, J and Nathan, D and Fritz, S and Crowell, S and Godine, J and McKitrick, C and Lou, P and Service, J and Ziegler, G and Pach, J and Colwell, J and Wood, D and Mayfield, R and Hermayer, K and Szpiech, M and Lyons, T and Parker, J and Farr, A and Elsing, S and Thompson, T and Molitch, M and Schaefer, B and Ja; (2001) 'Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)'. JOURNAL OF PEDIATRICS, 139 (6):804-812 [DOI] [Details]
(2001)'Management of hyperglycemic crises in patients with diabetes'
Kitabchi, AE and Umpierrez, GE and Murphy, MB and Barrett, EJ and Kreisberg, RA and Malone, JI and Wall, BM; (2001) 'Management of hyperglycemic crises in patients with diabetes'. DIABETES CARE, 24 (1):131-153 [Details]
(2001)'Drug therapy - Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension'
Murphy, MB and Murray, C and Shorten, GD; (2001) 'Drug therapy - Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension'. NEW ENGLAND JOURNAL OF MEDICINE, 345 (21):1548-1557 [Details]
(2000)'Beta-blockers blunt the morning surge in blood pressure and heart rate'
Leary, AC and Donnan, PT and MacDonald, TM and Murphy, MB; (2000) 'Beta-blockers blunt the morning surge in blood pressure and heart rate'. JOURNAL OF HYPERTENSION, 18 (Suppl. 2) [Details]
(2000)'Optimal dose of insulin for the treatment of diabetic ketoacidosis'
Peyton, J and Murphy, MB and Kitabchi, AE; (2000) 'Optimal dose of insulin for the treatment of diabetic ketoacidosis'. JOURNAL OF INVESTIGATIVE MEDICINE, 48 (1, Suppl. S) [Details]
(1999)'The characterization of I major myosin II phosphatase in Dictyostelium discoideum'
Murphy, MB and Levi, SK and Egelhoff, TT; (1999) 'The characterization of I major myosin II phosphatase in Dictyostelium discoideum'. MOLECULAR BIOLOGY OF THE CELL, 10 (Suppl. S) [Details]
(1999)'The magnitude of the morning surge is dependent an physical activity levels'
Leary, AC and Donnan, PT and MacDonald, TM and Murphy, MB; (1999) 'The magnitude of the morning surge is dependent an physical activity levels'. CIRCULATION, 100 (18, Suppl. S) [Details]
(1999)'Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease'
Hargrove, GM and Pasieka, JL and Hanley, DA and Murphy, MB; (1999) 'Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease'. AMERICAN JOURNAL OF NEPHROLOGY, 19 (5):559-564 [Details]
(1999)'beta-blockers blunt the morning surge in blood pressure and heart rate'
Leary, AC and Donnan, PT and MacDonald, TM and Murphy, MB; (1999) 'beta-blockers blunt the morning surge in blood pressure and heart rate'. HYPERTENSION, 34 (4, Part 1) [Details]
(1999)'Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort'
Genuth, S and Nathan, D and Shamoon, H and Duffy, H and Dahms, B and Mayer, L and Brillion, D and Lackaye, M and Whitehouse, F and Kruger, D and Bergenstal, R and Johnson, M and Jacobson, A and Doyle, J and Waters, M and Nathan, D and Crowell, S and Godine, J and McKitrick, C and Service, J and Ziegler, G and Colwell, J and Wood, D and Maytield, R and Molitch, M and Schaefer, B and Kolterman, O and Lorenzi, G and Sivitz, M and Bayless, M and Counts, D and Kowarski, A and Ostrowski, D and Greene, D and Martin, C and Bantle, J and Rogness, B and Goldstein, D and Smith, A and Schade, D and Johannes, C and Schwartz, S and Maschak-Carey, BJ and Orchard, T and Silvers, N and Malone, J and Mangione, A and Kitabchi, A and Murphy, MB and Raskin, P and Strowig, S and Zinman, B and Barnie, A and Pal; (1999) 'Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort'. DIABETES CARE, 22 (1):99-111 [Details]
(1998)'Biochemical and molecular characterization of myosin heavy chain phosphatase activity in Dictyostelium'
Murphy, MB and Bonner, ME and Levy, SK and Egelhoff, TT; (1998) 'Biochemical and molecular characterization of myosin heavy chain phosphatase activity in Dictyostelium'. MOLECULAR BIOLOGY OF THE CELL, 9 (Suppl. S) [Details]
(1998)'Daytime activity level is a determinant of nocturnal blood pressure fall'
Leary, AC and Murphy, MB and Shiels, P and Tim, PO and MacDonald, TM; (1998) 'Daytime activity level is a determinant of nocturnal blood pressure fall'. JOURNAL OF HYPERTENSION, 16 (Suppl. 2) [Details]
(1997)'Biochemical and molecular characterization of a PP2A type phosphatase which regulates filament assembly of Dictyostelium myosin II'
Murphy, MB and Bhat, S and Bonner, M and Egelhoff, TT; (1997) 'Biochemical and molecular characterization of a PP2A type phosphatase which regulates filament assembly of Dictyostelium myosin II'. MOLECULAR BIOLOGY OF THE CELL, 8 (Suppl. S) [Details]
(1997)'Gender disparities in arterial system properties in sustained and daytime hypertension'
Berger, DS and Shroff, SG and Murphy, MB and Bednarz, JE and Godoy, IE and Weinert, LC and Lang, RM; (1997) 'Gender disparities in arterial system properties in sustained and daytime hypertension'. CIRCULATION, 96 (8, Suppl. S) [Details]
(1997)'Escalating the dose of interferon does not increase the incidence of virologic response (VR) in patients with chronic hepatitis C'
Sterling, RK and Post, AB and Murphy, MB and Hoffman, RD and Jacobs, GH; (1997) 'Escalating the dose of interferon does not increase the incidence of virologic response (VR) in patients with chronic hepatitis C'. GASTROENTEROLOGY, 112 (4, Suppl. S) [Details]
(1997)'Escalating the dose of interferon fails to eradicate virus in chronic hepatitis C patients with normal aminotransferases'
Sterling, RK and Post, AB and Murphy, MB and Hoffman, RD and Jacobs, GH; (1997) 'Escalating the dose of interferon fails to eradicate virus in chronic hepatitis C patients with normal aminotransferases'. GASTROENTEROLOGY, 112 (4, Suppl. S) [Details]
(1997)'Flow cytometric analysis of DNA ploidy in patients with chronic hepatitis C (CHC): A pilot study on the effects of interferon (IFN)'
Sterling, RK and Wong, JW and Cooper, GS and Murphy, MB and Jacobs, GH; (1997) 'Flow cytometric analysis of DNA ploidy in patients with chronic hepatitis C (CHC): A pilot study on the effects of interferon (IFN)'. GASTROENTEROLOGY, 112 (4, Suppl. S) [Details]
(1996)'Purification and characterization of a myosin heavy chain phosphatase from Dictyostelium'
Murphy, MB and Cote, GP and Egelhoff, TT; (1996) 'Purification and characterization of a myosin heavy chain phosphatase from Dictyostelium'. MOLECULAR BIOLOGY OF THE CELL, 7 (Suppl. S) [Details]
(1996)'Novel use of an electrical bioimpedance technique to detect opioid-induced changes in gastric emptying'
Murphy, DB and Sutton, JA and Murphy, MB; (1996) 'Novel use of an electrical bioimpedance technique to detect opioid-induced changes in gastric emptying'. BRITISH JOURNAL OF ANAESTHESIA, 76 (Suppl. 2) [Details]
(1995)'BIOCHEMICAL-CHARACTERIZATION OF MYOSIN HEAVY-CHAIN PHOSPHATASE-ACTIVITY IN DICTYOSTELIUM'
MURPHY, MB and COTE, GP and EGELHOFF, TT; (1995) 'BIOCHEMICAL-CHARACTERIZATION OF MYOSIN HEAVY-CHAIN PHOSPHATASE-ACTIVITY IN DICTYOSTELIUM'. MOLECULAR BIOLOGY OF THE CELL, 6 (Suppl. S) [Details]
(1995)'DIFFERENTIAL-EFFECTS OF CHRONIC ORAL ANTIHYPERTENSIVE THERAPIES ON SYSTEMIC ARTERIAL CIRCULATION AND VENTRICULAR ENERGETICS IN AFRICAN-AMERICAN PATIENTS'
CHOLLEY, BP and SHROFF, SG and SANDELSKI, J and KORCARZ, C and BALASIA, BA and JAIN, S and BERGER, DS and MURPHY, MB and MARCUS, RH and LANG, RM; (1995) 'DIFFERENTIAL-EFFECTS OF CHRONIC ORAL ANTIHYPERTENSIVE THERAPIES ON SYSTEMIC ARTERIAL CIRCULATION AND VENTRICULAR ENERGETICS IN AFRICAN-AMERICAN PATIENTS'. CIRCULATION, 91 (4):1052-1062 [Details]
(1995)'NOCTURNAL BLOOD-PRESSURE DIPPING - A CONSEQUENCE OF DIURNAL PHYSICAL-ACTIVITY BLIPPING'
OSHEA, JC and MURPHY, MB; (1995) 'NOCTURNAL BLOOD-PRESSURE DIPPING - A CONSEQUENCE OF DIURNAL PHYSICAL-ACTIVITY BLIPPING'. CIRCULATION, 92 (8, Suppl. S) [Details]
(1994)'ETHNIC-DIFFERENCES IN CIRCADIAN HEMODYNAMIC PROFILE'
GRETLER, DD and FUMO, MT and NELSON, KS and MURPHY, MB; (1994) 'ETHNIC-DIFFERENCES IN CIRCADIAN HEMODYNAMIC PROFILE'. AMERICAN JOURNAL OF HYPERTENSION, 7 (1):7-14 [Details]
(1993)'FENOLDOPAM MESYLATE VERSUS SODIUM-NITROPRUSSIDE IN THE ACUTE MANAGEMENT OF SEVERE SYSTEMIC HYPERTENSION'
PILMER, BL and GREEN, JA and PANACEK, EA and ELLIOT, WJ and MURPHY, MB and RUTHERFORD, W and NARA, AR; (1993) 'FENOLDOPAM MESYLATE VERSUS SODIUM-NITROPRUSSIDE IN THE ACUTE MANAGEMENT OF SEVERE SYSTEMIC HYPERTENSION'. JOURNAL OF CLINICAL PHARMACOLOGY, 33 (6):549-553 [Details]
(1993)'COMPARISON OF 2 NONINVASIVE SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION'
ELLIOTT, WJ and MARTIN, WB and MURPHY, MB; (1993) 'COMPARISON OF 2 NONINVASIVE SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION'. ARCHIVES OF INTERNAL MEDICINE, 153 (6):755-764 [Details]
(1993)'LOW PREDICTIVE VALUE OF POSITIVE OSLER MANEUVER FOR DIAGNOSING PSEUDOHYPERTENSION'
OLINER, CM and ELLIOTT, WJ and GRETLER, DD and MURPHY, MB; (1993) 'LOW PREDICTIVE VALUE OF POSITIVE OSLER MANEUVER FOR DIAGNOSING PSEUDOHYPERTENSION'. JOURNAL OF HUMAN HYPERTENSION, 7 (1):65-70 [Details]
(1993)'SYSTEMIC AND PULMONARY HEMODYNAMIC-EFFECTS OF ACUTE BLOOD-PRESSURE REDUCTION WITH FENOLDOPAM (F) VS NITROPRUSSIDE (N)'
GRETLER, DD and GLOCK, D and JONES, KC and MURPHY, MB; (1993) 'SYSTEMIC AND PULMONARY HEMODYNAMIC-EFFECTS OF ACUTE BLOOD-PRESSURE REDUCTION WITH FENOLDOPAM (F) VS NITROPRUSSIDE (N)'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 53 (2) [Details]
(1993)'DIURNAL BLOOD-PRESSURE VARIABILITY AND PHYSICAL-ACTIVITY MEASURED ELECTRONICALLY AND BY DIARY'
GRETLER, DD and CARLSON, GF and MONTANO, AV and MURPHY, MB; (1993) 'DIURNAL BLOOD-PRESSURE VARIABILITY AND PHYSICAL-ACTIVITY MEASURED ELECTRONICALLY AND BY DIARY'. AMERICAN JOURNAL OF HYPERTENSION, 6 (2):127-133 [Details]
(1992)'BLOOD-PRESSURE AND FITNESS FOR WORK'
MURPHY, MB; (1992) 'BLOOD-PRESSURE AND FITNESS FOR WORK'. AMERICAN JOURNAL OF HYPERTENSION, 5 (5, Part 1):253-256 [Details]
(1992)'FENOLDOPAM TREATMENT DOES NOT ATTENUATE THE RENAL EFFECTS OF FUROSEMIDE IN MALIGNANT HYPERTENSION'
ELLIOTT, WJ and MURPHY, MB; (1992) 'FENOLDOPAM TREATMENT DOES NOT ATTENUATE THE RENAL EFFECTS OF FUROSEMIDE IN MALIGNANT HYPERTENSION'. CLINICAL RESEARCH, 40 (2) [Details]
(1992)'DIURNAL BLOOD-PRESSURE VARIATION AND CARDIAC MASS IN AMERICAN BLACKS AND WHITES AND SOUTH-AFRICAN BLACKS'
FUMO, MT and TEEGER, S and LANG, RM and BEDNARZ, J and SARELI, P and MURPHY, MB; (1992) 'DIURNAL BLOOD-PRESSURE VARIATION AND CARDIAC MASS IN AMERICAN BLACKS AND WHITES AND SOUTH-AFRICAN BLACKS'. AMERICAN JOURNAL OF HYPERTENSION, 5 (3):111-116 [Details]
(1992)'NICARDIPINE ALTERS DIURNAL URINARY-EXCRETION PATTERN'
GRETLER, DD and MONTANO, A and VALENTINEBATES, B and MURPHY, MB; (1992) 'NICARDIPINE ALTERS DIURNAL URINARY-EXCRETION PATTERN'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 51 (2) [Details]
(1992)'5-HYDROXYTRYPTAMINE RECEPTOR ACTIVITY OF THE DOPAMINE RECEPTOR AGONIST FENOLDOPAM IN CANINE TRACHEAL SMOOTH-MUSCLE'
GRETLER, DD and JONES, KC and MURPHY, MB; (1992) '5-HYDROXYTRYPTAMINE RECEPTOR ACTIVITY OF THE DOPAMINE RECEPTOR AGONIST FENOLDOPAM IN CANINE TRACHEAL SMOOTH-MUSCLE'. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 260 (2):491-498 [Details]
(1991)'ANTAGONISM OF THE VASCULAR EFFECTS OF FENOLDOPAM BY ALLOPURINOL IN THE RAT'
YAACOUB, AS and SHAO, ZH and MURPHY, MB; (1991) 'ANTAGONISM OF THE VASCULAR EFFECTS OF FENOLDOPAM BY ALLOPURINOL IN THE RAT'. CLINICAL RESEARCH, 39 (3) [Details]
(1991)'RENAL EFFECTS OF FUROSEMIDE IN MALIGNANT HYPERTENSION - COMPARISON FOLLOWING FENOLDOPAM OR NITROPRUSSIDE'
ELLIOTT, WJ and MURPHY, MB; (1991) 'RENAL EFFECTS OF FUROSEMIDE IN MALIGNANT HYPERTENSION - COMPARISON FOLLOWING FENOLDOPAM OR NITROPRUSSIDE'. CLINICAL RESEARCH, 39 (3) [Details]
(1991)'DIURNAL HEART-RATE VARIATION AND CARDIAC-HYPERTROPHY'
GRETLER, DD and LANG, RM and JAUHAR, R and FUMO, MT and WEINERT, L and MURPHY, MB; (1991) 'DIURNAL HEART-RATE VARIATION AND CARDIAC-HYPERTROPHY'. CLINICAL RESEARCH, 39 (3) [Details]
(1991)'DIURNAL BLOOD-PRESSURE AND URINARY CATECHOLAMINE EXCRETION IN UNITED-STATES BLACKS AND WHITES'
MURPHY, MB and FUMO, MT and OSINSKI, J and GRETLER, DD; (1991) 'DIURNAL BLOOD-PRESSURE AND URINARY CATECHOLAMINE EXCRETION IN UNITED-STATES BLACKS AND WHITES'. CLINICAL RESEARCH, 39 (3) [Details]
(1991)'ANGIOTENSIN CONVERTING ENZYME (ACE)-INHIBITORS AND TISSUE-SPECIFIC AUTOANTIBODIES'
JANIQA, AM and MURPHY, MB and ELLIOTT, WJ and YAACOUB, A and SOLTANI, KM; (1991) 'ANGIOTENSIN CONVERTING ENZYME (ACE)-INHIBITORS AND TISSUE-SPECIFIC AUTOANTIBODIES'. CLINICAL RESEARCH, 39 (3) [Details]
(1991)'A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED COMPARISON OF THE METABOLIC EFFECTS OF LOW-DOSE HYDROCHLOROTHIAZIDE AND INDAPAMIDE'
ELLIOTT, WJ and WEBER, RR and MURPHY, MB; (1991) 'A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED COMPARISON OF THE METABOLIC EFFECTS OF LOW-DOSE HYDROCHLOROTHIAZIDE AND INDAPAMIDE'. JOURNAL OF CLINICAL PHARMACOLOGY, 31 (8):751-757 [Details]
(1991)'ECG-CHANGES DURING ACUTE TREATMENT OF HYPERTENSIVE EMERGENCIES - FENOLDOPAM (F) VERSUS NITROPRUSSIDE (N)'
GRETLER, DD and ELLIOTT, WJ and MOSCUCCI, M and MURPHY, MB; (1991) 'ECG-CHANGES DURING ACUTE TREATMENT OF HYPERTENSIVE EMERGENCIES - FENOLDOPAM (F) VERSUS NITROPRUSSIDE (N)'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 49 (2) [Details]
(1991)'ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY'
WINKER, MA and MURPHY, MB; (1991) 'ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY'. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 265 (24):3301-3302 [Details]
(1991)'LONG-TERM PRESERVATION OF RENAL-FUNCTION IN HYPERTENSIVE HEART-TRANSPLANT RECIPIENTS TREATED WITH ENALAPRIL AND A DIURETIC'
ELLIOTT, WJ and MURPHY, MB and KARP, R; (1991) 'LONG-TERM PRESERVATION OF RENAL-FUNCTION IN HYPERTENSIVE HEART-TRANSPLANT RECIPIENTS TREATED WITH ENALAPRIL AND A DIURETIC'. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 10 (3):373-379 [Details]
(1991)'INFLUENCE OF DIURETIC THERAPY ON THE CLONIDINE SUPPRESSION TEST'
GRETLER, DD and GRAMELSPACHER, GP and FUMO, MT and ELLIOTT, WJ and MURPHY, MB; (1991) 'INFLUENCE OF DIURETIC THERAPY ON THE CLONIDINE SUPPRESSION TEST'. JOURNAL OF CLINICAL PHARMACOLOGY, 31 (5):448-454 [Details]
(1991)'DOPAMINE RECEPTOR AGONISTS IN CARDIOVASCULAR MEDICINE'
HORN, PT and MURPHY, MB; (1991) 'DOPAMINE RECEPTOR AGONISTS IN CARDIOVASCULAR MEDICINE'. TRENDS IN CARDIOVASCULAR MEDICINE, 1 (3):103-107 [Details]
(1991)'PERIPHERAL DOPAMINE-RECEPTORS IN CARDIOVASCULAR THERAPY - THE LEGACY OF GOLDBERG,LEON (1927-1989)'
KOHLI, JD and MCNAY, JL and RAJFER, SI and MURPHY, MB; (1991) 'PERIPHERAL DOPAMINE-RECEPTORS IN CARDIOVASCULAR THERAPY - THE LEGACY OF GOLDBERG,LEON (1927-1989)'. HYPERTENSION, 17 (5):700-706 [Details]
(1991)'ENDOGENOUS DOPAMINE AND THE RENAL RESPONSE TO ISCHEMIA'
SHAO, ZH and YAACOUB, AS and BASS, AS and MURPHY, MB; (1991) 'ENDOGENOUS DOPAMINE AND THE RENAL RESPONSE TO ISCHEMIA'. CLINICAL RESEARCH, 39 (2) [Details]
(1991)'ACUTE BLOOD-PRESSURE REDUCTION WITH FENOLDOPAM AND NITROPRUSSIDE - EFFECTS ON CORONARY BLOOD-FLOW'
GRETLER, DD and GLOCK, D and MURPHY, MB; (1991) 'ACUTE BLOOD-PRESSURE REDUCTION WITH FENOLDOPAM AND NITROPRUSSIDE - EFFECTS ON CORONARY BLOOD-FLOW'. CLINICAL RESEARCH, 39 (2) [Details]
(1991)'DA1 DOPAMINE RECEPTOR MODULATION AND THE RENAL RESPONSE TO ISCHEMIA'
YAACOUB, AS and SHAO, ZH and BASS, AS and MURPHY, MB; (1991) 'DA1 DOPAMINE RECEPTOR MODULATION AND THE RENAL RESPONSE TO ISCHEMIA'. CLINICAL RESEARCH, 39 (2) [Details]
(1991)'INTRAOCULAR-PRESSURE INCREASES WITH FENOLDOPAM, BUT NOT NITROPRUSSIDE, IN HYPERTENSIVE HUMANS'
ELLIOTT, WJ and KARNEZIS, TA and SILVERMAN, RA and GEANON, J and TRIPATHI, RC and MURPHY, MB; (1991) 'INTRAOCULAR-PRESSURE INCREASES WITH FENOLDOPAM, BUT NOT NITROPRUSSIDE, IN HYPERTENSIVE HUMANS'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 49 (3):285-293 [Details]
(1990)'EQUIVALENT ANTIHYPERTENSIVE EFFECTS OF COMBINATION THERAPY USING DIURETIC + CALCIUM-ANTAGONIST COMPARED WITH DIURETIC + ACE INHIBITOR'
ELLIOTT, WJ and POLASCIK, TB and MURPHY, MB; (1990) 'EQUIVALENT ANTIHYPERTENSIVE EFFECTS OF COMBINATION THERAPY USING DIURETIC + CALCIUM-ANTAGONIST COMPARED WITH DIURETIC + ACE INHIBITOR'. JOURNAL OF HUMAN HYPERTENSION, 4 (6):717-723 [Details]
(1990)'NEW DOPAMINE RECEPTOR AGONISTS IN HEART-FAILURE AND HYPERTENSION - IMPLICATIONS FOR FUTURE THERAPY'
HORN, PT and MURPHY, MB; (1990) 'NEW DOPAMINE RECEPTOR AGONISTS IN HEART-FAILURE AND HYPERTENSION - IMPLICATIONS FOR FUTURE THERAPY'. DRUGS, 40 (4):487-492 [Details]
(1990)'VALIDATION OF A NEW NONINVASIVE METHOD FOR DETERMINATION OF AORTIC COMPLIANCE'
MCCRAY, G and MARCUS, R and KORCARZ, C and NEUMANN, A and SARELI, P and ESSOP, R and MIDDLEMOST, S and MURPHY, MB and BOROW, KM and LANG, RM; (1990) 'VALIDATION OF A NEW NONINVASIVE METHOD FOR DETERMINATION OF AORTIC COMPLIANCE'. CLINICAL RESEARCH, 38 (3) [Details]
(1990)'WILLIAMS SYNDROME IN TWINS'
MURPHY, MB and GREENBERG, F and WILSON, G and HUGHES, M and DILIBERTI, J; (1990) 'WILLIAMS SYNDROME IN TWINS'. AMERICAN JOURNAL OF MEDICAL GENETICS, (Suppl. 6):97-99 [Details]
(1990)'WHITE COAT HYPERTENSION IN AN ELDERLY CLINIC POPULATION'
WINKER, MA and FUMO, MA and GRETLER, DD and MURPHY, MB; (1990) 'WHITE COAT HYPERTENSION IN AN ELDERLY CLINIC POPULATION'. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 38 (8) [Details]
(1990)'THERAPEUTIC APPLICATIONS OF DRUGS ACTING ON PERIPHERAL DOPAMINE-RECEPTORS'
HORN, PT and MURPHY, MB; (1990) 'THERAPEUTIC APPLICATIONS OF DRUGS ACTING ON PERIPHERAL DOPAMINE-RECEPTORS'. JOURNAL OF CLINICAL PHARMACOLOGY, 30 (8):674-679 [Details]
(1990)'INTRAVENOUS FENOLDOPAM IMPROVES RENAL-FUNCTION COMPARED TO NITROPRUSSIDE DURING THE ACUTE TREATMENT OF SEVERE HYPERTENSION'
ELLIOTT, WJ and WEBER, RR and NELSON, KS and OLINER, CM and FUMO, MT and GRETLER, DD and MCCRAY, GR and MURPHY, MB; (1990) 'INTRAVENOUS FENOLDOPAM IMPROVES RENAL-FUNCTION COMPARED TO NITROPRUSSIDE DURING THE ACUTE TREATMENT OF SEVERE HYPERTENSION'. EUROPEAN JOURNAL OF PHARMACOLOGY, 183 (3) [Details]
(1990)'CEREBRAL BLOOD-FLOW DURING THE ACUTE THERAPY OF SEVERE HYPERTENSION WITH ORAL CLONIDINE'
GREENE, CS and GRETLER, DD and CERVENKA, K and MCCOY, CE and BROWN, FD and MURPHY, MB; (1990) 'CEREBRAL BLOOD-FLOW DURING THE ACUTE THERAPY OF SEVERE HYPERTENSION WITH ORAL CLONIDINE'. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 8 (4):293-296 [Details]
(1990)'SEROTONERGIC ACTIVITY OF FENOLDOPAM IN CANINE TRACHEAL SMOOTH-MUSCLE (TSM)'
GRETLER, DD and JONES, KC and MITCHELL, RW and POPOVICH, KJ and MURPHY, MB; (1990) 'SEROTONERGIC ACTIVITY OF FENOLDOPAM IN CANINE TRACHEAL SMOOTH-MUSCLE (TSM)'. CLINICAL RESEARCH, 38 (2) [Details]
(1990)'RENAL AND HEMODYNAMIC-EFFECTS OF INTRAVENOUS FENOLDOPAM VERSUS NITROPRUSSIDE IN SEVERE HYPERTENSION'
ELLIOTT, WJ and WEBER, RR and NELSON, KS and OLINER, CM and FUMO, MT and GRETLER, DD and MCCRAY, GR and MURPHY, MB; (1990) 'RENAL AND HEMODYNAMIC-EFFECTS OF INTRAVENOUS FENOLDOPAM VERSUS NITROPRUSSIDE IN SEVERE HYPERTENSION'. CIRCULATION, 81 (3):970-977 [Details]
(1990)'FENOLDOPAM AND INTRAOCULAR-PRESSURE (IOP)'
ELLIOTT, WJ and KARNEZIS, T and SILVERMAN, RA and GEANON, J and TRIPATHI, RC and MURPHY, MB; (1990) 'FENOLDOPAM AND INTRAOCULAR-PRESSURE (IOP)'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 47 (2) [Details]
(1990)'RENAL EFFECTS OF A NOVEL DOPA DECARBOXYLASE INHIBITOR, DIFLUOROMETHYLDOPA'
BASS, AS and MURPHY, MB and JONES, K and YAACOUB, A; (1990) 'RENAL EFFECTS OF A NOVEL DOPA DECARBOXYLASE INHIBITOR, DIFLUOROMETHYLDOPA'. KIDNEY INTERNATIONAL, 37 (1) [Details]
(1989)'VERAPAMIL + DIURETIC LOWERS BLOOD-PRESSURE AS EFFECTIVELY AS ENALAPRIL + DIURETIC'
ELLIOTT, WJ and POLASCIK, T and MURPHY, MB; (1989) 'VERAPAMIL + DIURETIC LOWERS BLOOD-PRESSURE AS EFFECTIVELY AS ENALAPRIL + DIURETIC'. CLINICAL RESEARCH, 37 (4) [Details]
(1989)'EFFECTS OF DOPAMINE RECEPTOR ACTIVATION ON THE LEVEL OF CYCLIC-AMP IN THE TRABECULAR MESHWORK'
KARNEZIS, TA and TRIPATHI, BJ and DAWSON, G and MURPHY, MB and TRIPATHI, RC; (1989) 'EFFECTS OF DOPAMINE RECEPTOR ACTIVATION ON THE LEVEL OF CYCLIC-AMP IN THE TRABECULAR MESHWORK'. INVESTIGATIVE OPHTHALMOLOGY \& VISUAL SCIENCE, 30 (6):1090-1094 [Details]
(1989)'DIURETIC TREATMENT DOES NOT ALTER CLONIDINE SUPPRESSION OF PLASMA NOREPINEPHRINE CONCENTRATIONS'
GRAMELSPACHER, GP and GRETLER, D and FUMO, MT and GEORGE, M and ELLIOTT, WJ and MURPHY, MB; (1989) 'DIURETIC TREATMENT DOES NOT ALTER CLONIDINE SUPPRESSION OF PLASMA NOREPINEPHRINE CONCENTRATIONS'. CLINICAL RESEARCH, 37 (2) [Details]
(1989)'INHIBITION OF SODIUM HYDROGEN-EXCHANGE IN HUMAN-PLATELETS BY CLONIDINE'
GRETLER, D and FROHLICH, B and MURPHY, MB; (1989) 'INHIBITION OF SODIUM HYDROGEN-EXCHANGE IN HUMAN-PLATELETS BY CLONIDINE'. CLINICAL RESEARCH, 37 (2) [Details]
(1989)'CONGENITAL-SYPHILIS - DEVELOPMENTAL OUTCOME IN EARLY-CHILDHOOD'
MURPHY, MB and WILLIAMSON, WD and TABER, LH; (1989) 'CONGENITAL-SYPHILIS - DEVELOPMENTAL OUTCOME IN EARLY-CHILDHOOD'. PEDIATRIC RESEARCH, 25 (4, Part 2) [Details]
(1989)'POTENTIATION BY DOPEXAMINE OF THE CARDIAC RESPONSES TO CIRCULATING AND NEURONALLY RELEASED NOREPINEPHRINE - A POSSIBLE MECHANISM FOR THE THERAPEUTIC EFFECTS OF THE DRUG'
BASS, AS and MURPHY, MB and KOHLI, JD and GOLDBERG, LI; (1989) 'POTENTIATION BY DOPEXAMINE OF THE CARDIAC RESPONSES TO CIRCULATING AND NEURONALLY RELEASED NOREPINEPHRINE - A POSSIBLE MECHANISM FOR THE THERAPEUTIC EFFECTS OF THE DRUG'. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 13 (4):667-671 [Details]
(1989)'BETA-BLOCKADE AND MENTAL PERFORMANCE'
OLINER, CM and MURPHY, MB; (1989) 'BETA-BLOCKADE AND MENTAL PERFORMANCE'. ARCHIVES OF INTERNAL MEDICINE, 149 (2) [Details]
(1989)'IMPROVED SAFETY OF GLUCAGON TESTING FOR PHEOCHROMOCYTOMA BY PRIOR ALPHA-RECEPTOR BLOCKADE - A CONTROLLED TRIAL IN A PATIENT WITH A MIXED GANGLIONEUROMA PHEOCHROMOCYTOMA'
ELLIOTT, WJ and MURPHY, MB and STRAUS, FH and JARABAK, J; (1989) 'IMPROVED SAFETY OF GLUCAGON TESTING FOR PHEOCHROMOCYTOMA BY PRIOR ALPHA-RECEPTOR BLOCKADE - A CONTROLLED TRIAL IN A PATIENT WITH A MIXED GANGLIONEUROMA PHEOCHROMOCYTOMA'. ARCHIVES OF INTERNAL MEDICINE, 149 (1):214-216 [Details]
(1988)'DIABETIC-KETOACIDOSIS AND HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC COMA'
KITABCHI, AE and MURPHY, MB; (1988) 'DIABETIC-KETOACIDOSIS AND HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC COMA'. MEDICAL CLINICS OF NORTH AMERICA, 72 (6):1545-1563 [Details]
(1988)'COMPARISON OF THE EFFECTS OF DOPAMINE AND FENOLDOPAM, A SELECTIVE DOPAMINE-1 AGONIST, ON PARATHYROID-HORMONE RELEASE IN MAN'
BAKRIS, GL and WEBER, RR and NELSON, K and ELLIOTT, WJ and KAPLAN, E and MURPHY, MB; (1988) 'COMPARISON OF THE EFFECTS OF DOPAMINE AND FENOLDOPAM, A SELECTIVE DOPAMINE-1 AGONIST, ON PARATHYROID-HORMONE RELEASE IN MAN'. MINERAL AND ELECTROLYTE METABOLISM, 14 (6):343-346 [Details]
(1988)'DOPAMINE-RECEPTORS AND INTRAOCULAR-PRESSURE'
KARNEZIS, TA and MURPHY, MB; (1988) 'DOPAMINE-RECEPTORS AND INTRAOCULAR-PRESSURE'. TRENDS IN PHARMACOLOGICAL SCIENCES, 9 (11):389-390 [Details]
(1988)'EFFECTS OF SELECTIVE DOPAMINE-1 RECEPTOR ACTIVATION ON INTRAOCULAR-PRESSURE IN MAN'
KARNEZIS, TA and MURPHY, MB and WEBER, RR and NELSON, KS and TRIPATHI, BJ and TRIPATHI, RC; (1988) 'EFFECTS OF SELECTIVE DOPAMINE-1 RECEPTOR ACTIVATION ON INTRAOCULAR-PRESSURE IN MAN'. EXPERIMENTAL EYE RESEARCH, 47 (5):689-697 [Details]
(1988)'NOCTURNAL BLOOD-PRESSURE - AN IMPORTANT DETERMINANT OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS'
LANG, RM and BOROW, KM and WEINERT, L and BEDNARZ, J and NEUMANN, A and NELSON, K and DAVID, D and MURPHY, MB; (1988) 'NOCTURNAL BLOOD-PRESSURE - AN IMPORTANT DETERMINANT OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS'. CLINICAL RESEARCH, 36 (6) [Details]
(1988)'THE ROLE OF ALPHA-ADRENOCEPTOR BLOCKADE IN THE ANTIHYPERTENSIVE EFFECTS OF FENOLDOPAM IN HUMANS'
MURPHY, MB and WEBER, RR and NELSON, K and GOLDBERG, LI; (1988) 'THE ROLE OF ALPHA-ADRENOCEPTOR BLOCKADE IN THE ANTIHYPERTENSIVE EFFECTS OF FENOLDOPAM IN HUMANS'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 44 (1):49-55 [Details]
(1988)'REDUCED SPECIFICITY OF THE CLONIDINE SUPPRESSION TEST IN PATIENTS WITH NORMAL PLASMA-CATECHOLAMINE LEVELS'
ELLIOTT, WJ and MURPHY, MB; (1988) 'REDUCED SPECIFICITY OF THE CLONIDINE SUPPRESSION TEST IN PATIENTS WITH NORMAL PLASMA-CATECHOLAMINE LEVELS'. AMERICAN JOURNAL OF MEDICINE, 84 (3, Part 1):419-424 [Details]
(1988)'INDUCTION OF TISSUE-SPECIFIC AUTOANTIBODIES BY CAPTOPRIL'
BI, CK and SOLTANI, K and SLOAN, JB and SUTHIPINITTHARM, P and WEBER, RR and ELLIOTT, WJ and MURPHY, MB; (1988) 'INDUCTION OF TISSUE-SPECIFIC AUTOANTIBODIES BY CAPTOPRIL'. CLINICAL RESEARCH, 36 (3) [Details]
(1988)'INDUCTION OF TISSUE-SPECIFIC AUTOANTIBODIES BY CAPTOPRIL'
BI, CK and SOLTANI, K and SLOAN, JB and SUTHIPINITTHARM, P and WEBER, RR and ELLIOTT, WJ and MURPHY, MB; (1988) 'INDUCTION OF TISSUE-SPECIFIC AUTOANTIBODIES BY CAPTOPRIL'. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 90 (4) [Details]
(1988)'PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF INTRAVENOUS FENOLDOPAM, A DOPAMINE1-RECEPTOR AGONIST, IN HYPERTENSIVE PATIENTS'
WEBER, RR and MCCOY, CE and ZIEMNIAK, JA and FREDERICKSON, ED and GOLDBERG, LI and MURPHY, MB; (1988) 'PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF INTRAVENOUS FENOLDOPAM, A DOPAMINE1-RECEPTOR AGONIST, IN HYPERTENSIVE PATIENTS'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 25 (1):17-21 [Details]
(1988)'DISSOCIATION OF THE NATRIURESIS FOLLOWING EXTRA-CELLULAR FLUID VOLUME EXPANSION WITH 0.9-PERCENT NACL FROM URINARY DOPAMINE EXCRETION IN ANESTHETIZED RATS'
BASS, AS and MURPHY, MB; (1988) 'DISSOCIATION OF THE NATRIURESIS FOLLOWING EXTRA-CELLULAR FLUID VOLUME EXPANSION WITH 0.9-PERCENT NACL FROM URINARY DOPAMINE EXCRETION IN ANESTHETIZED RATS'. KIDNEY INTERNATIONAL, 33 (1) [Details]
(1987)'AUGMENTATION OF RENAL BLOOD-FLOW AND SODIUM-EXCRETION IN HYPERTENSIVE PATIENTS DURING BLOOD-PRESSURE REDUCTION BY INTRAVENOUS ADMINISTRATION OF THE DOPAMINE1 AGONIST FENOLDOPAM'
MURPHY, MB and MCCOY, CE and WEBER, RR and FREDERICKSON, ED and DOUGLAS, FL and GOLDBERG, LI; (1987) 'AUGMENTATION OF RENAL BLOOD-FLOW AND SODIUM-EXCRETION IN HYPERTENSIVE PATIENTS DURING BLOOD-PRESSURE REDUCTION BY INTRAVENOUS ADMINISTRATION OF THE DOPAMINE1 AGONIST FENOLDOPAM'. CIRCULATION, 76 (6):1312-1318 [Details]
(1987)'THE DIASTOLIC EFFECTS OF DOPEXAMINE, DOPAMINE AND NITROPRUSSIDE IN CARDIOMYOPATHY'
CARROLL, JD and LANG, RM and PAIK, GY and BOROW, KM and MURPHY, MB and RAJFER, SI; (1987) 'THE DIASTOLIC EFFECTS OF DOPEXAMINE, DOPAMINE AND NITROPRUSSIDE IN CARDIOMYOPATHY'. CIRCULATION, 76 (4, Part 2 Suppl. S) [Details]
(1987)'THE DIASTOLIC EFFECTS OF DOPEXAMINE, DOPAMINE AND NITROPRUSSIDE IN CARDIOMYOPATHY'
CARROLL, JD and LANG, RM and PAIK, GY and BOROW, KM and MURPHY, MB and RAJFER, SI; (1987) 'THE DIASTOLIC EFFECTS OF DOPEXAMINE, DOPAMINE AND NITROPRUSSIDE IN CARDIOMYOPATHY'. CLINICAL RESEARCH, 35 (6) [Details]
(1987)'REPRODUCIBILITY OF NONINVASIVE BLOOD-PRESSURE MONITORING BY SUNTECH ACCUTRACKER'
NELSON, KS and MURPHY, MB; (1987) 'REPRODUCIBILITY OF NONINVASIVE BLOOD-PRESSURE MONITORING BY SUNTECH ACCUTRACKER'. CLINICAL RESEARCH, 35 (6) [Details]
(1987)'PARATHYROID-HORMONE (PTH) SECRETION INCREASES FOLLOWING INFUSION OF DOPAMINE (D) BUT NOT FENOLDOPAM (F), A SELECTIVE DOPAMINE-1 (DA1) RECEPTOR AGONIST, IN MAN'
BAKRIS, GL and WEBER, R and NELSON, K and KAPLAN, E and MURPHY, MB; (1987) 'PARATHYROID-HORMONE (PTH) SECRETION INCREASES FOLLOWING INFUSION OF DOPAMINE (D) BUT NOT FENOLDOPAM (F), A SELECTIVE DOPAMINE-1 (DA1) RECEPTOR AGONIST, IN MAN'. CLINICAL RESEARCH, 35 (6) [Details]
(1987)'TISSUE-SPECIFIC AUTOANTIBODIES INDUCED BY CAPTOPRIL'
BI, CK and SOLTANI, K and SLOAN, JB and WEBER, RR and ELLIOTT, WJ and MURPHY, MB; (1987) 'TISSUE-SPECIFIC AUTOANTIBODIES INDUCED BY CAPTOPRIL'. CLINICAL RESEARCH, 35 (6) [Details]
(1987)'FOLATE STATUS IN HYPERTENSIVE PATIENTS ON THE FOLATE ANTAGONIST, TRIAMTERENE'
MASON, JB and ZIMMERMAN, J and MURPHY, MB and ROSENBERG, IH; (1987) 'FOLATE STATUS IN HYPERTENSIVE PATIENTS ON THE FOLATE ANTAGONIST, TRIAMTERENE'. CLINICAL RESEARCH, 35 (3) [Details]
(1987)'MECHANISMS OF ANTIHYPERTENSIVE ACTIONS OF FENOLDOPAM IN MAN'
MURPHY, MB and WEBER, RR and NELSON, KS and GOLDBERG, LI; (1987) 'MECHANISMS OF ANTIHYPERTENSIVE ACTIONS OF FENOLDOPAM IN MAN'. CLINICAL RESEARCH, 35 (3) [Details]
(1987)'ENALAPRIL FOR HYPERTENSION AFTER CARDIAC TRANSPLANTATION'
ELLIOTT, WJ and MURPHY, MB and KARP, R and KAPELANSKI, D; (1987) 'ENALAPRIL FOR HYPERTENSION AFTER CARDIAC TRANSPLANTATION'. CLINICAL RESEARCH, 35 (3) [Details]
(1987)'BICARBONATE THERAPY IN SEVERE DIABETIC-KETOACIDOSIS - RESPONSE'
MORRIS, L and MURPHY, MB and KITABCHI, AE; (1987) 'BICARBONATE THERAPY IN SEVERE DIABETIC-KETOACIDOSIS - RESPONSE'. ANNALS OF INTERNAL MEDICINE, 106 (4) [Details]
(1987)'PHARMACOKINETICS OF INTRAVENOUS FENOLDOPAM IN HYPERTENSIVE PATIENTS'
WEBER, RR and MCCOY, CE and ZIEMNIAK, JA and GOLDBERG, LI and MURPHY, MB; (1987) 'PHARMACOKINETICS OF INTRAVENOUS FENOLDOPAM IN HYPERTENSIVE PATIENTS'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 41 (2) [Details]
(1986)'BICARBONATE THERAPY IN SEVERE DIABETIC-KETOACIDOSIS'
MORRIS, LR and MURPHY, MB and KITABCHI, AE; (1986) 'BICARBONATE THERAPY IN SEVERE DIABETIC-KETOACIDOSIS'. ANNALS OF INTERNAL MEDICINE, 105 (6):836-840 [Details]
(1986)'EFFECTS OF ATRIAL-NATRIURETIC-FACTOR ARE INDEPENDENT OF DOPAMINE (DA1) RECEPTOR ACTIVATION'
MURPHY, MB and GLOCK, D and LUBBERS, NL and GOLDBERG, LI; (1986) 'EFFECTS OF ATRIAL-NATRIURETIC-FACTOR ARE INDEPENDENT OF DOPAMINE (DA1) RECEPTOR ACTIVATION'. CLINICAL RESEARCH, 34 (2) [Details]
(1985)'INTRAVENOUS ADMINISTRATION OF THE DOPAMINE (DA1) RECEPTOR AGONIST, FENOLDOPAM, IN HYPERTENSIVE PATIENTS'
MURPHY, MB and MCCOY, CE and FREDERICKSON, ED and DOUGLAS, FL and GOLDBERG, LI; (1985) 'INTRAVENOUS ADMINISTRATION OF THE DOPAMINE (DA1) RECEPTOR AGONIST, FENOLDOPAM, IN HYPERTENSIVE PATIENTS'. JOURNAL OF HYPERTENSION, 3 (Suppl. 3) [Details]
(1985)'GLUCOSE-TOLERANCE DURING ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH DIABETES-MELLITUS'
STRUTHERS, AD and MURPHY, MB and DOLLERY, CT; (1985) 'GLUCOSE-TOLERANCE DURING ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH DIABETES-MELLITUS'. HYPERTENSION, 7 (6):95-101 [Details]
(1985)'THE EFFECTS OF NIFEDIPINE ON PLATELET-AGGREGATION AND PLASMA 6-KETO-PGF1-ALPHA, AND ITS INTERACTION WITH INDOMETHACIN'
MURPHY, MB and ORCHARD, MA and CONWAY, EL and BARROW, SE; (1985) 'THE EFFECTS OF NIFEDIPINE ON PLATELET-AGGREGATION AND PLASMA 6-KETO-PGF1-ALPHA, AND ITS INTERACTION WITH INDOMETHACIN'. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 29 (4):413-416 [Details]
(1985)'TREATMENT OF HYPERTENSION WITH CALCIUM-ANTAGONISTS'
MURPHY, MB; (1985) 'TREATMENT OF HYPERTENSION WITH CALCIUM-ANTAGONISTS'. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 5 (5):287-291 [Details]
(1985)'BETA-BLOCKERS AND THE CNS - PROCEEDINGS OF AN INTERNATIONAL-SYMPOSIUM, AMSTERDAM, THE NETHERLANDS, 19 MAY 1984 - INTRODUCTION'
DOLLERY, CT and MURPHY, MB and DAVIES, HC; (1985) 'BETA-BLOCKERS AND THE CNS - PROCEEDINGS OF AN INTERNATIONAL-SYMPOSIUM, AMSTERDAM, THE NETHERLANDS, 19 MAY 1984 - INTRODUCTION'. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 28 (Suppl. S) [Details]
(1985)'ADRENERGIC SYSTEM AND POSTPRANDIAL PLASMA POTASSIUM HOMEOSTASIS'
MURPHY, MB and QUIGLEY, C and BROWN, MJ; (1985) 'ADRENERGIC SYSTEM AND POSTPRANDIAL PLASMA POTASSIUM HOMEOSTASIS'. CLINICAL RESEARCH, 33 (2) [Details]
(1985)'INTRAVENOUS ADMINISTRATION OF THE DOPAMINE (DA1) RECEPTOR AGONIST, FENOLDOPAM, IN HYPERTENSIVE PATIENTS'
MCCOY, CE and FREDERICKSON, ED and DOUGLAS, FL and MURPHY, MB and GOLDBERG, LI; (1985) 'INTRAVENOUS ADMINISTRATION OF THE DOPAMINE (DA1) RECEPTOR AGONIST, FENOLDOPAM, IN HYPERTENSIVE PATIENTS'. CLINICAL RESEARCH, 33 (2) [Details]
(1984)'LOCATION OF VASCULAR ALPHA-2-ADRENOCEPTORS IN MAN'
MURPHY, MB and BROWN, MJ and DOLLERY, CT; (1984) 'LOCATION OF VASCULAR ALPHA-2-ADRENOCEPTORS IN MAN'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 18 (6):955-958 [Details]
(1984)'NIFEDIPINE AND ALPHA ADRENOCEPTOR ANTAGONISM'
MURPHY, MB and BROWN, MJ and SCRIVEN, AJI and HEAVEY, DJ and DOLLERY, CT; (1984) 'NIFEDIPINE AND ALPHA ADRENOCEPTOR ANTAGONISM'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 36 (6):745-749 [Details]
(1984)'EFFECT OF CENTRALLY ACTING ALPHA-ADRENERGIC AGONISTS ON SYMPATHETIC NERVOUS-SYSTEM FUNCTION IN HUMANS'
BROWN, MJ and HARLAND, D and MURPHY, MB and STRUTHERS, AD; (1984) 'EFFECT OF CENTRALLY ACTING ALPHA-ADRENERGIC AGONISTS ON SYMPATHETIC NERVOUS-SYSTEM FUNCTION IN HUMANS'. HYPERTENSION, 6 (5):57-62 [Details]
(1984)'EVIDENCE FOR A PERIPHERAL COMPONENT IN THE SYMPATHOLYTIC ACTIONS OF CLONIDINE AND GUANFACINE IN MAN'
MURPHY, MB and BROWN, MJ and DOLLERY, CT; (1984) 'EVIDENCE FOR A PERIPHERAL COMPONENT IN THE SYMPATHOLYTIC ACTIONS OF CLONIDINE AND GUANFACINE IN MAN'. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 27 (1):23-27 [Details]
(1984)'CHANGES IN BLOOD-PRESSURE AND PLASMA-CATECHOLAMINES CAUSED BY TYRAMINE AND COLD-EXPOSURE'
SCRIVEN, AJI and BROWN, MJ and MURPHY, MB and DOLLERY, CT; (1984) 'CHANGES IN BLOOD-PRESSURE AND PLASMA-CATECHOLAMINES CAUSED BY TYRAMINE AND COLD-EXPOSURE'. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 6 (5):954-960 [Details]
(1984)'ROLE OF NIFEDIPINE IN THE TREATMENT OF RESISTANT HYPERTENSION - COMPARISON WITH HYDRALAZINE IN HOSPITAL OUTPATIENTS'
MURPHY, MB and BULPITT, CJ and DOLLERY, CT; (1984) 'ROLE OF NIFEDIPINE IN THE TREATMENT OF RESISTANT HYPERTENSION - COMPARISON WITH HYDRALAZINE IN HOSPITAL OUTPATIENTS'. AMERICAN JOURNAL OF MEDICINE, 77 (2B):16-21 [Details]
(1984)'EFFECTS OF SHORT-TERM BETA-ADRENORECEPTOR BLOCKADE ON SERUM-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH HYPERTENSION OR CORONARY-ARTERY DISEASE'
MURPHY, MB and SUGRUE, D and TRAYNER, I and KAUFMAN, S and YASUHARA, H and DOLLERY, CT and THOMPSON, GR; (1984) 'EFFECTS OF SHORT-TERM BETA-ADRENORECEPTOR BLOCKADE ON SERUM-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH HYPERTENSION OR CORONARY-ARTERY DISEASE'. BRITISH HEART JOURNAL, 51 (6):589-594 [Details]
(1984)'DOES HYPERTHYROIDISM PREDISPOSE TO THIORIDAZINE-INDUCED HYPERPYREXIA AND CARDIAC-ARRHYTHMIAS'
MURPHY, MB and FITZGERALD, MX; (1984) 'DOES HYPERTHYROIDISM PREDISPOSE TO THIORIDAZINE-INDUCED HYPERPYREXIA AND CARDIAC-ARRHYTHMIAS'. POSTGRADUATE MEDICAL JOURNAL, 60 (704):445-446 [Details]
(1984)'BETA-ADRENOCEPTOR BLOCKERS AND SERUM-LIPIDS'
MURPHY, MB and SUGRUE, D and TRAYNOR, I and YASUHARA, H and THOMPSON, GT; (1984) 'BETA-ADRENOCEPTOR BLOCKERS AND SERUM-LIPIDS'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 17 (5) [Details]
(1984)'HYPOKALEMIA FROM BETA-2-RECEPTOR STIMULATION BY EPINEPHRINE - REPLY'
BROWN, MJ and MURPHY, MB; (1984) 'HYPOKALEMIA FROM BETA-2-RECEPTOR STIMULATION BY EPINEPHRINE - REPLY'. NEW ENGLAND JOURNAL OF MEDICINE, 310 (20) [Details]
(1984)'ATOPY, IMMUNOLOGICAL CHANGES, AND RESPIRATORY-FUNCTION IN BRONCHIECTASIS'
MURPHY, MB and REEN, DJ and FITZGERALD, MX; (1984) 'ATOPY, IMMUNOLOGICAL CHANGES, AND RESPIRATORY-FUNCTION IN BRONCHIECTASIS'. THORAX, 39 (3):179-184 [Details]
(1984)'IS NIFEDIPINE AN ALPHA-ADRENOCEPTOR ANTAGONIST IN MAN'
MURPHY, MB and BROWN, MJ; (1984) 'IS NIFEDIPINE AN ALPHA-ADRENOCEPTOR ANTAGONIST IN MAN'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 17 (2) [Details]
(1983)'HYPOKALEMIA FROM BETA-2-RECEPTOR STIMULATION BY CIRCULATING EPINEPHRINE'
BROWN, MJ and BROWN, DC and MURPHY, MB; (1983) 'HYPOKALEMIA FROM BETA-2-RECEPTOR STIMULATION BY CIRCULATING EPINEPHRINE'. NEW ENGLAND JOURNAL OF MEDICINE, 309 (23):1414-1419 [Details]
(1983)'THE EFFECTS OF PENTOLINIUM ON SYMPATHETIC ACTIVITY IN HYPERTENSIVES AND NORMOTENSIVE CONTROLS'
MURPHY, MB and BROWN, MJ and CAUSON, RC and DOLLERY, CT; (1983) 'THE EFFECTS OF PENTOLINIUM ON SYMPATHETIC ACTIVITY IN HYPERTENSIVES AND NORMOTENSIVE CONTROLS'. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 3 (4):227-232 [Details]
(1983)'CALCIUM-ANTAGONISTS IN HYPERTENSION - PREFACE'
DOLLERY, CT and MURPHY, MB; (1983) 'CALCIUM-ANTAGONISTS IN HYPERTENSION - PREFACE'. HYPERTENSION, 5 (4) [Details]
(1983)'EFFICACY OF NIFEDIPINE AS A STEP-3 ANTIHYPERTENSIVE DRUG'
MURPHY, MB and SCRIVEN, AJI and DOLLERY, CT; (1983) 'EFFICACY OF NIFEDIPINE AS A STEP-3 ANTIHYPERTENSIVE DRUG'. HYPERTENSION, 5 (4):118-121 [Details]
(1983)'ROLE OF NIFEDIPINE IN TREATMENT OF HYPERTENSION'
MURPHY, MB and SCRIVEN, AJI and DOLLERY, CT; (1983) 'ROLE OF NIFEDIPINE IN TREATMENT OF HYPERTENSION'. BRITISH MEDICAL JOURNAL, 287 (6387):257-259 [Details]
(1983)'THE USE OF CONTINUOUS INSULIN DELIVERY SYSTEMS IN TREATMENT OF DIABETES-MELLITUS'
KITABCHI, AE and FISHER, JN and MATTERI, R and MURPHY, MB; (1983) 'THE USE OF CONTINUOUS INSULIN DELIVERY SYSTEMS IN TREATMENT OF DIABETES-MELLITUS'. ADVANCES IN INTERNAL MEDICINE, 28 :449-490 [Details]
(1983)'BLOOD-PRESSURE AND PLASMA NOREPINEPHRINE CONCENTRATIONS AFTER ENDOGENOUS NOREPINEPHRINE RELEASE BY TYRAMINE'
SCRIVEN, AJI and DOLLERY, CT and MURPHY, MB and MACQUIN, I and BROWN, MJ; (1983) 'BLOOD-PRESSURE AND PLASMA NOREPINEPHRINE CONCENTRATIONS AFTER ENDOGENOUS NOREPINEPHRINE RELEASE BY TYRAMINE'. CLINICAL PHARMACOLOGY \& THERAPEUTICS, 33 (6):710-716 [Details]
(1983)'ADRENALINE ASSOCIATED HYPOKALEMIA AND TACHYCARDIA ARE SELECTIVELY ANTAGONIZED BY LOW-DOSE BETA-2-RECEPTOR BLOCKADE IN MAN'
BROWN, MJ and BROWN, DC and MURPHY, MB; (1983) 'ADRENALINE ASSOCIATED HYPOKALEMIA AND TACHYCARDIA ARE SELECTIVELY ANTAGONIZED BY LOW-DOSE BETA-2-RECEPTOR BLOCKADE IN MAN'. CLINICAL SCIENCE, 64 (2) [Details]
(1983)'HYPOTENSION AND THE PENTOLINIUM SUPPRESSION TEST'
MURPHY, MB and CAUSON, R; (1983) 'HYPOTENSION AND THE PENTOLINIUM SUPPRESSION TEST'. LANCET, 1 (8335) [Details]
(1983)'CHEST PERCUSSION - HELP OR HINDRANCE TO POSTURAL DRAINAGE'
MURPHY, MB and CONCANNON, D and FITZGERALD, MX; (1983) 'CHEST PERCUSSION - HELP OR HINDRANCE TO POSTURAL DRAINAGE'. IRISH MEDICAL JOURNAL, 76 (4):189-190 [Details]
(1982)'THE EFFECTS OF NIFEDIPINE AND HYDRALAZINE INDUCED HYPOTENSION ON SYMPATHETIC ACTIVITY'
MURPHY, MB and SCRIVEN, AJ and BROWN, MJ and CAUSON, R and DOLLERY, CT; (1982) 'THE EFFECTS OF NIFEDIPINE AND HYDRALAZINE INDUCED HYPOTENSION ON SYMPATHETIC ACTIVITY'. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 23 (6):479-482 [Details]
(1982)'GLUCOSE-INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS - A 14-YEAR FOLLOW-UP'
MURPHY, MB and KOHNER, E and LEWIS, PJ and SCHUMER, B; (1982) 'GLUCOSE-INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS - A 14-YEAR FOLLOW-UP'. LANCET, 2 (8311):1293-1295 [Details]
(1982)'THE DIABETIC PATIENT WHO MISTREATED HERSELF'
KITABCHI, AE and MURPHY, MB; (1982) 'THE DIABETIC PATIENT WHO MISTREATED HERSELF'. HOSPITAL PRACTICE, 17 (9):196-197 [Details]
(1982)'REVERSIBILITY OF DIURETIC INDUCED GLUCOSE-INTOLERANCE'
MURPHY, MB and KOHNER, EM and DOLLERY, CT and LEWIS, PJ; (1982) 'REVERSIBILITY OF DIURETIC INDUCED GLUCOSE-INTOLERANCE'. CLINICAL SCIENCE, 63 (3) [Details]
(1982)'OPTIMAL INSULIN DELIVERY IN DIABETIC-KETOACIDOSIS (DKA) AND HYPERGLYCEMIC, HYPER-OSMOLAR NON-KETOTIC COMA (HHNC)'
KITABCHI, AE and MATTERI, R and MURPHY, MB; (1982) 'OPTIMAL INSULIN DELIVERY IN DIABETIC-KETOACIDOSIS (DKA) AND HYPERGLYCEMIC, HYPER-OSMOLAR NON-KETOTIC COMA (HHNC)'. DIABETES CARE, 5 (Suppl. 1):78-87 [Details]
(1982)'CHANGES IN BLOOD-PRESSURE AND PLASMA NORADRENALINE WITH INFUSIONS OF TYRAMINE AND NORADRENALINE IN NORMAL SUBJECTS'
SCRIVEN, AJI and DOLLERY, CT and BROWN, MJ and MACQUIN, I and MURPHY, MB and CAUSON, RC; (1982) 'CHANGES IN BLOOD-PRESSURE AND PLASMA NORADRENALINE WITH INFUSIONS OF TYRAMINE AND NORADRENALINE IN NORMAL SUBJECTS'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 13 (4) [Details]
(1982)'GLUCOSE-TOLERANCE AFTER 14-YEARS OF DIURETIC THERAPY'
DOLLERY, CT and KOHNER, EM and LEWIS, PJ and MURPHY, MB; (1982) 'GLUCOSE-TOLERANCE AFTER 14-YEARS OF DIURETIC THERAPY'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 13 (4) [Details]
(1982)'THE EFFECT OF PENTOLINIUM ON PLASMA-CATECHOLAMINES IN HYPERTENSIVES AND NORMAL CONTROLS'
MURPHY, MB and BROWN, MJ and CAUSON, R and IND, PW and SCRIVEN, AJ; (1982) 'THE EFFECT OF PENTOLINIUM ON PLASMA-CATECHOLAMINES IN HYPERTENSIVES AND NORMAL CONTROLS'. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 13 (4) [Details]
(1982)'EFFECT OF HEMOLYSIS ON RADIOENZYMIC ASSAY OF PLASMA-CATECHOLAMINES'
CAUSON, RC and MURPHY, MB and BROWN, MJ; (1982) 'EFFECT OF HEMOLYSIS ON RADIOENZYMIC ASSAY OF PLASMA-CATECHOLAMINES'. CLINICAL CHEMISTRY, 28 (3):548-550 [Details]
(1982)'SUSTAINED INCREASE IN SYMPATHETIC ACTIVITY DUE TO NEURONAL UPTAKE OF ADRENALINE - MECHANISM FOR STRESS-INDUCED HYPERTENSION AND ARRHYTHMIAS'
BROWN, MJ and MACQUIN, I and MURPHY, MB and DOLLERY, CT; (1982) 'SUSTAINED INCREASE IN SYMPATHETIC ACTIVITY DUE TO NEURONAL UPTAKE OF ADRENALINE - MECHANISM FOR STRESS-INDUCED HYPERTENSION AND ARRHYTHMIAS'. CLINICAL SCIENCE, 62 (2) [Details]
(1981)'IGG SUBCLASS LEVELS IN HEALTHY IRISH ADULTS - A POPULATION STUDY'
REEN, DJ and MURPHY, MB and OCONNOR, A and FITZGERALD, MX; (1981) 'IGG SUBCLASS LEVELS IN HEALTHY IRISH ADULTS - A POPULATION STUDY'. IRISH JOURNAL OF MEDICAL SCIENCE, 150 (9):265-269 [Details]
(1980)'THEOPHYLLINE AND DEPRESSION'
MURPHY, MB and DILLON, A and FITZGERALD, MX; (1980) 'THEOPHYLLINE AND DEPRESSION'. BRITISH MEDICAL JOURNAL, 281 (6251) [Details]

Other Journals

 YearPublication
(2000)'Beta-blockers blunt the morning surge in blood pressure and heart rate'
Leary AC, Donnan PT, MacDonald TM, Murphy MB; (2000) 'Beta-blockers blunt the morning surge in blood pressure and heart rate' Journal of Hypertension, 18 . [Details]

Professional Activities

Conference Contributions

 YearPublication
(2003)Australian National Cardiology Summit,
Murphy, M.B.; (2003) The PROSPER Study. [Invited Lectures (Conference)], Australian National Cardiology Summit, Queensland , 01-JAN-03 - 01-JAN-03. [Details]
(2003)Middle East Cardiology Symposium,
Murphy, M.B.; (2003) Treatment of cardiovascular risk factors in the elderly¿. [Invited Lectures (Conference)], Middle East Cardiology Symposium, Luxor, Egypt , 01-JAN-03 - 01-JAN-03. [Details]
(2002)National Cardiology Congress Turkey,
Murphy, M.B.; (2002) Safety and Tolerability of Pravastatin in long-term Clinical Trials. [Invited Lectures (Conference)], National Cardiology Congress Turkey, Antalya, Turkey , 01-JAN-02 - 01-JAN-02. [Details]
(1999)Venezuelan Society of Hypertension,
Murphy, M.B.; (1999) Dopamine and Hypertension. [Invited Lectures (Conference)], Venezuelan Society of Hypertension, Caracas, Venezuela , 01-JAN-99 - 01-JAN-99. [Details]
(1999)Barcelona, Spain,
Murphy, M.B.; (1999) Care of the Older Patient: Managing Multiple Risk Factors. [Invited Lectures (Conference)], Barcelona, Spain, European Society of Cardiology , 01-JAN-99 - 01-JAN-99. [Details]
(1999)Irish Pharmaceutical Healthcare Association,
Murphy, M.B.; (1999) Research and the Pharmaceutical Industry in Ireland. [Invited Lectures (Conference)], Irish Pharmaceutical Healthcare Association, Cork , 01-JAN-99 - 01-JAN-99. [Details]
(1997)Fondazione Internazionale,
Murphy, M.B.; (1997) Clinical Trials with Pravastatin. [Invited Lectures (Conference)], Fondazione Internazionale, Menarini. Rome , 01-JAN-97 - 01-JAN-97. [Details]
(1996)Biennial Cheeca Symposium,
Murphy, M.B.; (1996) Ambulatory Blood Pressure Monitoring - State of the Art. [Invited Lectures (Conference)], Biennial Cheeca Symposium, Islamorada, Florida, USA , 01-JAN-96 - 01-JAN-96. [Details]
(1996)Plenary Lecture to the Irish Association of Pharmacologists,
Murphy, M.B.; (1996) Dopamine Receptor Modulation of the Renal Response to Ischaemia. [Invited Lectures (Conference)], Plenary Lecture to the Irish Association of Pharmacologists, Galway , 01-JAN-96 - 01-JAN-96. [Details]
(1994)Irish Association for Internal Medicine,
Murphy, M.B.; (1994) Medical Education for the 21st Century. [Invited Lectures (Conference)], Irish Association for Internal Medicine, Kinsale.Co. Cork , 01-JAN-94 - 01-JAN-94. [Details]
(1993)European Blood Pressure Group,
Murphy, M.B.; (1993) Modulation of renal ischaemia by vascular dopamine receptors. [Invited Lectures (Conference)], European Blood Pressure Group, Gilleleje, Denmark , 01-JAN-93 - 01-JAN-93. [Details]
(1993)Moving Points in Medicine Symposium,
Murphy, M.B.; (1993) Recent developments in the daignosis, investigation and treatment of hypertension. [Invited Lectures (Conference)], Moving Points in Medicine Symposium, Royal College of Physicians in Ireland.Dublin , 01-JAN-93 - 01-JAN-93. [Details]
(1992)Fourth International Conference on Peripheral Dopamine,
Murphy, M.B.; (1992) Modulation of the Renal Response to Ischemia by Dopamine Receptor Agonists. [Invited Lectures (Conference)], Fourth International Conference on Peripheral Dopamine, Oporto, Portugal , 01-JAN-92 - 01-JAN-92. [Details]
(1992)American Society for Clinical Pharmacology and Therapeutics,
Murphy, M.B.; (1992) Dopamine Receptor Agonists. [Invited Lectures (Conference)], American Society for Clinical Pharmacology and Therapeutics, Orlando, FL , 01-JAN-92 - 01-JAN-92. [Details]
(1991)Second International Consensus Conference on Ambulatory Blood Pressure Monitoring,
Murphy, M.B.; (1991) Ethnic Differences in Diurnal Blood Pressure Profiles. [Invited Lectures (Conference)], Second International Consensus Conference on Ambulatory Blood Pressure Monitoring, Dublin, Ireland , 01-JAN-91 - 01-JAN-91. [Details]
(1991)American College of Clinical Pharmacology,
Murphy, M.B.; (1991) Drug use in Special Populations - The Old, Young or Pregnant. [Invited Lectures (Conference)], American College of Clinical Pharmacology, Washington, DC , 01-JAN-91 - 01-JAN-91. [Details]
(1990)Italian Cardiac Society,
Murphy, M.B.; (1990) Role of the Sympathetic Nervous System in Hypertension. [Invited Lectures (Conference)], Italian Cardiac Society, Rome, Italy , 01-JAN-90 - 01-JAN-90. [Details]
(1990)European Society on Critical Care Medicine,
Murphy, M.B.; (1990) Renal Dysfunction in Severe Hypertension. [Invited Lectures (Conference)], European Society on Critical Care Medicine, Brussels, Belgium , 01-JAN-90 - 01-JAN-90. [Details]
(1990)Western Pharmacological Society (US),
Murphy, M.B.; (1990) Clinical use of Dopamine Receptor Agonists. [Invited Lectures (Conference)], Western Pharmacological Society (US), Banff, Canada , 01-JAN-90 - 01-JAN-90. [Details]

Contact details

Search profiles by name

Search profiles by topic

Department of Pharmacology and Therapeutics

Cógaseolaíocht agus Teiripic

2nd Floor, Western Gateway Building, University College Cork, Cork

Top